CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Audiovisual Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03569865
NCT03569865N/ACompleted
CompareCT.gov

Audio-visual Stimulation: Sleep Dose Response

University of Washington·interventional·Posted Jun 26, 2018·Updated Jan 20, 2022

In Brief

A clinical study evaluating Audiovisual Stimulation for Insomnia Chronic and 2 related conditions. Completed, enrolled 72 participants across 1 site.

Detailed Summary

Osteoarthritis (OA) pain affects 50 percent of older adults, more than half of whom also experience significant sleep disturbance. This study examines the impact of an innovative audiovisual stimulation (AVS) program on human brainwaves, and its usefulness to improve sleep. The AVS intervention, if demonstrated to be efficacious for sleep promotion, could benefit millions of people worldwide.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInsomnia Chronic, Osteoarthritis, Pain, Chronic
CountriesUnited States
CollaboratorsNational Institute of Nursing Research (NINR)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 26, 2018
Enrollment StartMar 15, 2019
Primary CompletionOct 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 8.0 years ago

Interventions

Audiovisual Stimulationdevice

A commercially available AVS device (MindPlace Procyon) modified for use in the current study will be used to deliver the AVS programs in this study.